Myovant Sciences Ltd. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Myovant Sciences Ltd. had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $106.20 million as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2023-01-26
- 2022-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $106.20M.
- 2022-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $108.50M.
- 2022-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $112.10M.
- 2022-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $83.00M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2022-12-31 | $106.20M 10-Q · filed 2023-01-26 |
| 2022-09-30 | $108.50M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $112.10M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $83.00M 10-K · filed 2022-05-11 |
| 2021-12-31 | $88.80M 10-Q · filed 2022-01-26 |
| 2021-09-30 | $109.60M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $102.20M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $62.40M 10-K · filed 2021-05-11 |
| 2020-12-31 | $66.60M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $65.20M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $69.30M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $52.30M 10-K · filed 2020-05-18 |
| 2019-12-31 | $58.80M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $78.20M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $65.20M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $45.20M 10-K · filed 2019-05-24 |
| 2018-12-31 | $48.60M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $49.30M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $47.90M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $33.70M 10-K · filed 2018-06-07 |